0000950170-23-041528.txt : 20230810
0000950170-23-041528.hdr.sgml : 20230810
20230810185605
ACCESSION NUMBER: 0000950170-23-041528
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230810
FILED AS OF DATE: 20230810
DATE AS OF CHANGE: 20230810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cannon Gillian
CENTRAL INDEX KEY: 0001833910
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36687
FILM NUMBER: 231161076
MAIL ADDRESS:
STREET 1: C/O CORCEPT THERAPEUTICS INCORPORATED
STREET 2: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001582313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980661854
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
BUSINESS PHONE: (604) 484-3300
MAIL ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
4
1
ownership.xml
4
X0508
4
2023-08-10
0001582313
Xenon Pharmaceuticals Inc.
XENE
0001833910
Cannon Gillian
200 - 3650 GILMORE WAY
BURNABY
Z4
V5G 4W8
CANADA (FEDERAL LEVEL)
true
false
false
false
false
Stock Option (Right to Buy)
38.39
2023-08-10
4
A
false
28000
0
A
2033-08-09
Common Shares
28000
28000
D
One-third of the total shares subject to the Option shall vest on the first anniversary of August 8, 2023 (the "Start Date"), one-third on the second anniversary of the Start Date and the balance on the third anniversary of the Start Date.
/s/ Cassandra Robinson, Attorney-in-fact
2023-08-10